Skip to main content
Full access
Letter to the Editor
Published Online: 1 June 1999

Severe Vasculitis After Therapy With Diazepam

Publication: American Journal of Psychiatry
To the Editor: Diazepam is a benzodiazepine prescribed worldwide. In respect to its posology and indications, the drug is generally well tolerated. Hypersensitivity manifestations are very rare and of mild severity (1). The causative role of the drug in one case of allergic interstitial nephritis has been previously described (2). We have recently seen a patient who experienced bullous vasculitis, fever, and neutrophilia after therapy with diazepam.
Ms. A, a 50-year-old woman, was referred to our hospital for chronic depression or dysthymic disorder with alcohol dependence. There was no history of drug allergy. She was given 100 mg of thioridazine orally once a day and 10 mg of diazepam four times a day. After 2 days, she noticed an erythematous eruption on her ankles. Thioridazine treatment was first discontinued. As the eruption became more erythematous and affected both extremities and flanks within a few hours, methylprednisolone was administered at a dose of 80 mg daily. The next day, the eruption progressively became bullous, and Ms. A’s condition worsened. She felt ill and had pyrexia at 39.4˚C. Urea and creatinine levels stayed within normal limits. The results of blood cultures were negative. A skin biopsy revealed bullous vasculitis with numerous eosinophils within the dermis. Diazepam therapy was then discontinued, which led to the resolution of pyrexia and the progressive healing of the cutaneous lesions. Postinflammatory ulcers persisted on both ankles for 2 months. The results of a lymphocyte blast transformation test was positive for diazepam.
Cutaneous side effects of diazepam are very rare and of mild severity (1). To our knowledge, severe vasculitis from diazepam has not been previously reported. The imputability of the drug is strongly supported by the improvement of Ms. A’s condition after the discontinuation of diazepam and blastogenesis after in vitro exposure of her lymphocytes to the drug. We suggest that psychiatrists be aware of this potential side effect and allow prompt withdrawal of the drug.

References

1.
Edwards JG: Adverse effects of antianxiety drugs. Drugs 1981; 22:494–514
2.
Sadjadi SA, McLaughlin K, Shah RM: Allergic interstitial nephritis due to diazepam. Arch Intern Med 1987; 147:579

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 972a - 973
PubMed: 10360151

History

Published online: 1 June 1999
Published in print: June 1999

Authors

Affiliations

GENOVEVA MORAN OLCINA, M.D.
THIERRY SIMONART, M.D.
Brussels, Belgium

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share